Insulin Resistance Is Highly Prevalent and Is Associated With Reduced Exercise Tolerance in Nondiabetic Patients With Heart Failure

Objectives The purpose of this study was to establish the prevalence of insulin resistance (IR) among nondiabetic chronic heart failure (CHF) patients and to seek factors associated with IR in CHF, including the relationship of IR to functional class, exercise capacity, and disease severity in CHF....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2009-03, Vol.53 (9), p.747-753
Hauptverfasser: ALZadjali, Matlooba A., MD, MPH, Godfrey, Valerie, PhD, Khan, Faisel, PhD, Choy, AnnaMaria, FRCP, FACC, Doney, Alexander S., MD, Wong, Aaron K., MBChB, MRCP, Petrie, John R., MD, FRCP, Struthers, Allan D., MD, FRCP, Lang, Chim C., MD, FACC
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 753
container_issue 9
container_start_page 747
container_title Journal of the American College of Cardiology
container_volume 53
creator ALZadjali, Matlooba A., MD, MPH
Godfrey, Valerie, PhD
Khan, Faisel, PhD
Choy, AnnaMaria, FRCP, FACC
Doney, Alexander S., MD
Wong, Aaron K., MBChB, MRCP
Petrie, John R., MD, FRCP
Struthers, Allan D., MD, FRCP
Lang, Chim C., MD, FACC
description Objectives The purpose of this study was to establish the prevalence of insulin resistance (IR) among nondiabetic chronic heart failure (CHF) patients and to seek factors associated with IR in CHF, including the relationship of IR to functional class, exercise capacity, and disease severity in CHF. Background Several lines of evidence suggest that CHF is an IR state. The prevalence of IR in CHF and its relation to CHF have not been fully defined. Methods Fasting insulin resistance index (FIRI) was assessed in a cohort of 129 consecutive CHF patients (mean age 69.2 ± 10.4 years; 76% males; body mass index 27.4 ± 4.4 kg/m2 ). Patients underwent cardiopulmonary exercise testing and peripheral endothelial function testing by reactive hyperemia peripheral arterial tonometry (RH-PAT). Results Prevalence of IR as defined by FIRI ≥2.7 was 61% in our cohort of CHF patients. There was a significant correlation between IR and waist circumference (r = 0.37; p < 0.01), serum triglycerides (r = 0.34; p < 0.01), high-density lipoprotein cholesterol (r = −0.22; p = 0.02), and serum leptin (r = 0.39; p = 0.03). Insulin resistance increased significantly with worsening New York Heart Association functional class (p < 0.01). The CHF patients with IR had a significantly lower exercise capacity and peak oxygen consumption than patients with an FIRI
doi_str_mv 10.1016/j.jacc.2008.08.081
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66971585</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109708039326</els_id><sourcerecordid>66971585</sourcerecordid><originalsourceid>FETCH-LOGICAL-c532t-5d830de267af89233dd8c0bce49ced20a2fe378d8c899a4388935a05eb73fc4d3</originalsourceid><addsrcrecordid>eNqFkl9rFDEUxYModq1-AR9kQPRt1vyZZBKQQimtu1C0aMXHkE3u2KyzMzV3prjPfnEzu4uFPigEQi6_c5Lccwl5yeicUaberedr5_2cU6rnu8UekRmTUpdCmvoxmdFayJJRUx-RZ4hrSqnSzDwlR8zwShpVzcjvZYdjG7viM2DEwXUeiiUWi_j9pt0WVwnuXAvdULguTPVTxN5HN0AovsXhJqvC6PPh_BckHxGK676FtHPJnh_7LkS3giH64soNMRvhXrcAl4biwsV2TPCcPGlci_DisB-Trxfn12eL8vLTh-XZ6WXppeBDKYMWNABXtWu04UKEoD1deahMfgKnjjcgap2L2hhXCa2NkI5KWNWi8VUQx-Tt3vc29T9HwMFuInpoW9dBP6JVytRMavlfkFNZUcZEBl8_ANf9mLr8CcskVbxSjFaZ4nvKpx4xQWNvU9y4tLWM2ilJu7ZTknZK0u4Wy6JXB-txtYFwLzlEl4E3B8Chd20zdT3iX46zyU2pzL3fc5BbexchWfQ5idyymMAPNvTx3-84eSD3eVxivvEHbAHv_2uRW2q_TDM3jRzVVBjBlfgDIB_RBw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1506246104</pqid></control><display><type>article</type><title>Insulin Resistance Is Highly Prevalent and Is Associated With Reduced Exercise Tolerance in Nondiabetic Patients With Heart Failure</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>ALZadjali, Matlooba A., MD, MPH ; Godfrey, Valerie, PhD ; Khan, Faisel, PhD ; Choy, AnnaMaria, FRCP, FACC ; Doney, Alexander S., MD ; Wong, Aaron K., MBChB, MRCP ; Petrie, John R., MD, FRCP ; Struthers, Allan D., MD, FRCP ; Lang, Chim C., MD, FACC</creator><creatorcontrib>ALZadjali, Matlooba A., MD, MPH ; Godfrey, Valerie, PhD ; Khan, Faisel, PhD ; Choy, AnnaMaria, FRCP, FACC ; Doney, Alexander S., MD ; Wong, Aaron K., MBChB, MRCP ; Petrie, John R., MD, FRCP ; Struthers, Allan D., MD, FRCP ; Lang, Chim C., MD, FACC</creatorcontrib><description><![CDATA[Objectives The purpose of this study was to establish the prevalence of insulin resistance (IR) among nondiabetic chronic heart failure (CHF) patients and to seek factors associated with IR in CHF, including the relationship of IR to functional class, exercise capacity, and disease severity in CHF. Background Several lines of evidence suggest that CHF is an IR state. The prevalence of IR in CHF and its relation to CHF have not been fully defined. Methods Fasting insulin resistance index (FIRI) was assessed in a cohort of 129 consecutive CHF patients (mean age 69.2 ± 10.4 years; 76% males; body mass index 27.4 ± 4.4 kg/m2 ). Patients underwent cardiopulmonary exercise testing and peripheral endothelial function testing by reactive hyperemia peripheral arterial tonometry (RH-PAT). Results Prevalence of IR as defined by FIRI ≥2.7 was 61% in our cohort of CHF patients. There was a significant correlation between IR and waist circumference (r = 0.37; p < 0.01), serum triglycerides (r = 0.34; p < 0.01), high-density lipoprotein cholesterol (r = −0.22; p = 0.02), and serum leptin (r = 0.39; p = 0.03). Insulin resistance increased significantly with worsening New York Heart Association functional class (p < 0.01). The CHF patients with IR had a significantly lower exercise capacity and peak oxygen consumption than patients with an FIRI <2.7. The RH-PAT ratio was significantly lower in CHF patients with IR compared with CHF patients with an FIRI <2.7 (1.6 ± 0.3 vs. 2.0 ± 0.5; p < 0.05). Conclusions Insulin resistance is highly prevalent among nondiabetic CHF patients and is associated with decreased exercise capacity in patients with CHF. (Insulin Resistance: Heart Failure; NCT00486967 ).]]></description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2008.08.081</identifier><identifier>PMID: 19245964</identifier><identifier>CODEN: JACCDI</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Biological and medical sciences ; Blood pressure ; Body fat ; Body mass index ; Cardiology ; Cardiology. Vascular system ; Cardiovascular ; Cholesterol, HDL - blood ; Cohort Studies ; Confidence intervals ; Diabetes ; endothelial dysfunction ; Endothelium, Vascular - metabolism ; Endothelium, Vascular - physiopathology ; Enzymes ; exercise capacity ; Exercise Tolerance ; Female ; Glucose ; Heart ; Heart failure ; Heart Failure - blood ; Heart Failure - metabolism ; Heart Failure - physiopathology ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Humans ; Insulin ; Insulin Resistance ; Internal Medicine ; Leptin - blood ; Logistic Models ; Male ; Medical sciences ; Oxygen Consumption ; Plasma ; Prevalence ; Studies ; Triglycerides - blood ; United States - epidemiology</subject><ispartof>Journal of the American College of Cardiology, 2009-03, Vol.53 (9), p.747-753</ispartof><rights>American College of Cardiology Foundation</rights><rights>2009 American College of Cardiology Foundation</rights><rights>2009 INIST-CNRS</rights><rights>Copyright Elsevier Limited Mar 3, 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c532t-5d830de267af89233dd8c0bce49ced20a2fe378d8c899a4388935a05eb73fc4d3</citedby><cites>FETCH-LOGICAL-c532t-5d830de267af89233dd8c0bce49ced20a2fe378d8c899a4388935a05eb73fc4d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109708039326$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21200866$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19245964$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ALZadjali, Matlooba A., MD, MPH</creatorcontrib><creatorcontrib>Godfrey, Valerie, PhD</creatorcontrib><creatorcontrib>Khan, Faisel, PhD</creatorcontrib><creatorcontrib>Choy, AnnaMaria, FRCP, FACC</creatorcontrib><creatorcontrib>Doney, Alexander S., MD</creatorcontrib><creatorcontrib>Wong, Aaron K., MBChB, MRCP</creatorcontrib><creatorcontrib>Petrie, John R., MD, FRCP</creatorcontrib><creatorcontrib>Struthers, Allan D., MD, FRCP</creatorcontrib><creatorcontrib>Lang, Chim C., MD, FACC</creatorcontrib><title>Insulin Resistance Is Highly Prevalent and Is Associated With Reduced Exercise Tolerance in Nondiabetic Patients With Heart Failure</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description><![CDATA[Objectives The purpose of this study was to establish the prevalence of insulin resistance (IR) among nondiabetic chronic heart failure (CHF) patients and to seek factors associated with IR in CHF, including the relationship of IR to functional class, exercise capacity, and disease severity in CHF. Background Several lines of evidence suggest that CHF is an IR state. The prevalence of IR in CHF and its relation to CHF have not been fully defined. Methods Fasting insulin resistance index (FIRI) was assessed in a cohort of 129 consecutive CHF patients (mean age 69.2 ± 10.4 years; 76% males; body mass index 27.4 ± 4.4 kg/m2 ). Patients underwent cardiopulmonary exercise testing and peripheral endothelial function testing by reactive hyperemia peripheral arterial tonometry (RH-PAT). Results Prevalence of IR as defined by FIRI ≥2.7 was 61% in our cohort of CHF patients. There was a significant correlation between IR and waist circumference (r = 0.37; p < 0.01), serum triglycerides (r = 0.34; p < 0.01), high-density lipoprotein cholesterol (r = −0.22; p = 0.02), and serum leptin (r = 0.39; p = 0.03). Insulin resistance increased significantly with worsening New York Heart Association functional class (p < 0.01). The CHF patients with IR had a significantly lower exercise capacity and peak oxygen consumption than patients with an FIRI <2.7. The RH-PAT ratio was significantly lower in CHF patients with IR compared with CHF patients with an FIRI <2.7 (1.6 ± 0.3 vs. 2.0 ± 0.5; p < 0.05). Conclusions Insulin resistance is highly prevalent among nondiabetic CHF patients and is associated with decreased exercise capacity in patients with CHF. (Insulin Resistance: Heart Failure; NCT00486967 ).]]></description><subject>Biological and medical sciences</subject><subject>Blood pressure</subject><subject>Body fat</subject><subject>Body mass index</subject><subject>Cardiology</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular</subject><subject>Cholesterol, HDL - blood</subject><subject>Cohort Studies</subject><subject>Confidence intervals</subject><subject>Diabetes</subject><subject>endothelial dysfunction</subject><subject>Endothelium, Vascular - metabolism</subject><subject>Endothelium, Vascular - physiopathology</subject><subject>Enzymes</subject><subject>exercise capacity</subject><subject>Exercise Tolerance</subject><subject>Female</subject><subject>Glucose</subject><subject>Heart</subject><subject>Heart failure</subject><subject>Heart Failure - blood</subject><subject>Heart Failure - metabolism</subject><subject>Heart Failure - physiopathology</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Humans</subject><subject>Insulin</subject><subject>Insulin Resistance</subject><subject>Internal Medicine</subject><subject>Leptin - blood</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Oxygen Consumption</subject><subject>Plasma</subject><subject>Prevalence</subject><subject>Studies</subject><subject>Triglycerides - blood</subject><subject>United States - epidemiology</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkl9rFDEUxYModq1-AR9kQPRt1vyZZBKQQimtu1C0aMXHkE3u2KyzMzV3prjPfnEzu4uFPigEQi6_c5Lccwl5yeicUaberedr5_2cU6rnu8UekRmTUpdCmvoxmdFayJJRUx-RZ4hrSqnSzDwlR8zwShpVzcjvZYdjG7viM2DEwXUeiiUWi_j9pt0WVwnuXAvdULguTPVTxN5HN0AovsXhJqvC6PPh_BckHxGK676FtHPJnh_7LkS3giH64soNMRvhXrcAl4biwsV2TPCcPGlci_DisB-Trxfn12eL8vLTh-XZ6WXppeBDKYMWNABXtWu04UKEoD1deahMfgKnjjcgap2L2hhXCa2NkI5KWNWi8VUQx-Tt3vc29T9HwMFuInpoW9dBP6JVytRMavlfkFNZUcZEBl8_ANf9mLr8CcskVbxSjFaZ4nvKpx4xQWNvU9y4tLWM2ilJu7ZTknZK0u4Wy6JXB-txtYFwLzlEl4E3B8Chd20zdT3iX46zyU2pzL3fc5BbexchWfQ5idyymMAPNvTx3-84eSD3eVxivvEHbAHv_2uRW2q_TDM3jRzVVBjBlfgDIB_RBw</recordid><startdate>20090303</startdate><enddate>20090303</enddate><creator>ALZadjali, Matlooba A., MD, MPH</creator><creator>Godfrey, Valerie, PhD</creator><creator>Khan, Faisel, PhD</creator><creator>Choy, AnnaMaria, FRCP, FACC</creator><creator>Doney, Alexander S., MD</creator><creator>Wong, Aaron K., MBChB, MRCP</creator><creator>Petrie, John R., MD, FRCP</creator><creator>Struthers, Allan D., MD, FRCP</creator><creator>Lang, Chim C., MD, FACC</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7TS</scope><scope>7X8</scope></search><sort><creationdate>20090303</creationdate><title>Insulin Resistance Is Highly Prevalent and Is Associated With Reduced Exercise Tolerance in Nondiabetic Patients With Heart Failure</title><author>ALZadjali, Matlooba A., MD, MPH ; Godfrey, Valerie, PhD ; Khan, Faisel, PhD ; Choy, AnnaMaria, FRCP, FACC ; Doney, Alexander S., MD ; Wong, Aaron K., MBChB, MRCP ; Petrie, John R., MD, FRCP ; Struthers, Allan D., MD, FRCP ; Lang, Chim C., MD, FACC</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c532t-5d830de267af89233dd8c0bce49ced20a2fe378d8c899a4388935a05eb73fc4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Biological and medical sciences</topic><topic>Blood pressure</topic><topic>Body fat</topic><topic>Body mass index</topic><topic>Cardiology</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular</topic><topic>Cholesterol, HDL - blood</topic><topic>Cohort Studies</topic><topic>Confidence intervals</topic><topic>Diabetes</topic><topic>endothelial dysfunction</topic><topic>Endothelium, Vascular - metabolism</topic><topic>Endothelium, Vascular - physiopathology</topic><topic>Enzymes</topic><topic>exercise capacity</topic><topic>Exercise Tolerance</topic><topic>Female</topic><topic>Glucose</topic><topic>Heart</topic><topic>Heart failure</topic><topic>Heart Failure - blood</topic><topic>Heart Failure - metabolism</topic><topic>Heart Failure - physiopathology</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Humans</topic><topic>Insulin</topic><topic>Insulin Resistance</topic><topic>Internal Medicine</topic><topic>Leptin - blood</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Oxygen Consumption</topic><topic>Plasma</topic><topic>Prevalence</topic><topic>Studies</topic><topic>Triglycerides - blood</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ALZadjali, Matlooba A., MD, MPH</creatorcontrib><creatorcontrib>Godfrey, Valerie, PhD</creatorcontrib><creatorcontrib>Khan, Faisel, PhD</creatorcontrib><creatorcontrib>Choy, AnnaMaria, FRCP, FACC</creatorcontrib><creatorcontrib>Doney, Alexander S., MD</creatorcontrib><creatorcontrib>Wong, Aaron K., MBChB, MRCP</creatorcontrib><creatorcontrib>Petrie, John R., MD, FRCP</creatorcontrib><creatorcontrib>Struthers, Allan D., MD, FRCP</creatorcontrib><creatorcontrib>Lang, Chim C., MD, FACC</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Physical Education Index</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ALZadjali, Matlooba A., MD, MPH</au><au>Godfrey, Valerie, PhD</au><au>Khan, Faisel, PhD</au><au>Choy, AnnaMaria, FRCP, FACC</au><au>Doney, Alexander S., MD</au><au>Wong, Aaron K., MBChB, MRCP</au><au>Petrie, John R., MD, FRCP</au><au>Struthers, Allan D., MD, FRCP</au><au>Lang, Chim C., MD, FACC</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insulin Resistance Is Highly Prevalent and Is Associated With Reduced Exercise Tolerance in Nondiabetic Patients With Heart Failure</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2009-03-03</date><risdate>2009</risdate><volume>53</volume><issue>9</issue><spage>747</spage><epage>753</epage><pages>747-753</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><coden>JACCDI</coden><abstract><![CDATA[Objectives The purpose of this study was to establish the prevalence of insulin resistance (IR) among nondiabetic chronic heart failure (CHF) patients and to seek factors associated with IR in CHF, including the relationship of IR to functional class, exercise capacity, and disease severity in CHF. Background Several lines of evidence suggest that CHF is an IR state. The prevalence of IR in CHF and its relation to CHF have not been fully defined. Methods Fasting insulin resistance index (FIRI) was assessed in a cohort of 129 consecutive CHF patients (mean age 69.2 ± 10.4 years; 76% males; body mass index 27.4 ± 4.4 kg/m2 ). Patients underwent cardiopulmonary exercise testing and peripheral endothelial function testing by reactive hyperemia peripheral arterial tonometry (RH-PAT). Results Prevalence of IR as defined by FIRI ≥2.7 was 61% in our cohort of CHF patients. There was a significant correlation between IR and waist circumference (r = 0.37; p < 0.01), serum triglycerides (r = 0.34; p < 0.01), high-density lipoprotein cholesterol (r = −0.22; p = 0.02), and serum leptin (r = 0.39; p = 0.03). Insulin resistance increased significantly with worsening New York Heart Association functional class (p < 0.01). The CHF patients with IR had a significantly lower exercise capacity and peak oxygen consumption than patients with an FIRI <2.7. The RH-PAT ratio was significantly lower in CHF patients with IR compared with CHF patients with an FIRI <2.7 (1.6 ± 0.3 vs. 2.0 ± 0.5; p < 0.05). Conclusions Insulin resistance is highly prevalent among nondiabetic CHF patients and is associated with decreased exercise capacity in patients with CHF. (Insulin Resistance: Heart Failure; NCT00486967 ).]]></abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>19245964</pmid><doi>10.1016/j.jacc.2008.08.081</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2009-03, Vol.53 (9), p.747-753
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_miscellaneous_66971585
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Biological and medical sciences
Blood pressure
Body fat
Body mass index
Cardiology
Cardiology. Vascular system
Cardiovascular
Cholesterol, HDL - blood
Cohort Studies
Confidence intervals
Diabetes
endothelial dysfunction
Endothelium, Vascular - metabolism
Endothelium, Vascular - physiopathology
Enzymes
exercise capacity
Exercise Tolerance
Female
Glucose
Heart
Heart failure
Heart Failure - blood
Heart Failure - metabolism
Heart Failure - physiopathology
Heart failure, cardiogenic pulmonary edema, cardiac enlargement
Humans
Insulin
Insulin Resistance
Internal Medicine
Leptin - blood
Logistic Models
Male
Medical sciences
Oxygen Consumption
Plasma
Prevalence
Studies
Triglycerides - blood
United States - epidemiology
title Insulin Resistance Is Highly Prevalent and Is Associated With Reduced Exercise Tolerance in Nondiabetic Patients With Heart Failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T10%3A37%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insulin%20Resistance%20Is%20Highly%20Prevalent%20and%20Is%20Associated%20With%20Reduced%20Exercise%20Tolerance%20in%20Nondiabetic%20Patients%20With%20Heart%20Failure&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=ALZadjali,%20Matlooba%20A.,%20MD,%20MPH&rft.date=2009-03-03&rft.volume=53&rft.issue=9&rft.spage=747&rft.epage=753&rft.pages=747-753&rft.issn=0735-1097&rft.eissn=1558-3597&rft.coden=JACCDI&rft_id=info:doi/10.1016/j.jacc.2008.08.081&rft_dat=%3Cproquest_cross%3E66971585%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1506246104&rft_id=info:pmid/19245964&rft_els_id=S0735109708039326&rfr_iscdi=true